# Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

> **NCT00672802** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 26 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- COPD

## Interventions

- **DRUG:** Ramelteon and Placebo

## Key facts

- **NCT ID:** NCT00672802
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672802, "Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00672802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*